Exploració per altres contribucions "CVPath Institute"

Ara es mostren els items 1-2 de 2

    • Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces 

      Joner, M.; Cheng, Q.; Schönhofer-Merl, S.; Lopez, M.; Neubauer, S.; Mas Moruno, Carlos; Laufer, B.; Kolodgie, F.D.; Kessler, H.; Virmani, R. (2012)
      Article
      Accés restringit per política de l'editorial
      Realitzat a/amb:   Technische Universität München / CVPath Institute
      This study examined the utility of a stabilized cyclic RGD peptide chemically modified to selectively bind to titanium-oxide for enhanced biocompatibility of self-expanding nitinol stents. Endothelial cells express integrin ...

    • The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system 

      Rechenmacher, Florian; Steigerwald, Kristin; Laufer, Burkhardt; Neubauer, Stefanie; Kapp, Tobias G.; Li, Liang; Mas Moruno, Carlos; Joner, Michael; Kessler, Horst (2014-07-01)
      Article
      Accés restringit per política de l'editorial
      Realitzat a/amb:   Technische Universität München / Deutsches Herzzentrum München / CVPath Institute
      The use of highly active and selective integrin ligands in combination with stent implantation is emerging as a promising alternative to the release of classical immunosuppressive drugs by current drug-eluting stents (DES), ...